Enliven Therapeutics, Inc. financial data

Symbol
ELVN on Nasdaq, IMRA on NYSE
Location
6200 Lookout Road, Boulder, CO
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 12, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 2.66K % +96.8%
Debt-to-equity 3.86 % -50.4%
Return On Equity -24.9 % +15.5%
Return On Assets -24 % +12.4%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 59.3M shares +21.5%
Common Stock, Shares, Outstanding 59.3M shares +25.4%
Entity Public Float 684M USD +78.9%
Common Stock, Value, Issued 59K USD +25.5%
Weighted Average Number of Shares Outstanding, Basic 62.1M shares +28.6%
Weighted Average Number of Shares Outstanding, Diluted 62.1M shares +28.6%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 85.3M USD +9.46%
General and Administrative Expense 26.9M USD +20.1%
Operating Income (Loss) -112M USD -11.8%
Nonoperating Income (Expense) 15.1M USD -0.73%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -97.2M USD -14.1%
Earnings Per Share, Basic -1 USD/shares -6.98%
Earnings Per Share, Diluted -1 USD/shares -6.98%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 102M USD +1.1%
Marketable Securities, Current 376M USD +96.6%
Cash, Cash Equivalents, and Short-term Investments 478M USD +63.7%
Assets, Current 483M USD +62.5%
Property, Plant and Equipment, Net 399K USD -27.3%
Operating Lease, Right-of-Use Asset 475K USD +486%
Other Assets, Noncurrent 7.1M USD -1.92%
Assets 491M USD +60.7%
Accounts Payable, Current 1.43M USD +40.2%
Liabilities, Current 14.7M USD -14%
Operating Lease, Liability, Noncurrent 103K USD
Other Liabilities, Noncurrent 103K USD
Liabilities 14.8M USD -13.4%
Accumulated Other Comprehensive Income (Loss), Net of Tax 221K USD -8.68%
Retained Earnings (Accumulated Deficit) -317M USD -44.1%
Stockholders' Equity Attributable to Parent 476M USD +65.1%
Liabilities and Equity 491M USD +60.7%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -24.1M USD -3.28%
Net Cash Provided by (Used in) Financing Activities 234K USD -99.7%
Net Cash Provided by (Used in) Investing Activities 1.43M USD
Common Stock, Shares Authorized 100M shares 0%
Common Stock, Shares, Issued 59.3M shares +25.4%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 102M USD +1.05%
Deferred Tax Assets, Valuation Allowance 63.7M USD +48.9%
Deferred Tax Assets, Gross 63.7M USD +48.5%
Operating Lease, Liability 490K USD +476%
Depreciation 74K USD -6.33%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -97.2M USD -14.6%
Lessee, Operating Lease, Liability, to be Paid 514K USD +505%
Property, Plant and Equipment, Gross 1.54M USD +5.35%
Operating Lease, Liability, Current 387K USD +355%
Lessee, Operating Lease, Liability, to be Paid, Year One 414K USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 24K USD
Deferred Tax Assets, Operating Loss Carryforwards 24.6M USD +24.5%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 33.5M USD +4.08%
Operating Lease, Payments 100K USD +16.3%
Additional Paid in Capital 793M USD +56%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 279K USD -12.3%
Share-based Payment Arrangement, Expense 27M USD +51.2%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%